Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aterian Inc (ATER) vs McCormick & Company, Incorporated (MKC) Price & Performance

Aterian IncTrade
McCormick & Company, IncorporatedTrade

Price performance (Past 24H)

Key statistics

Aterian Inc vs McCormick & Company, Incorporated — how do they compare? Aterian Inc trades at $1.28 (market cap $12.98M), while McCormick & Company, Incorporated trades at $50.96 (market cap $14.21B). The key difference: McCormick & Company, Incorporated is far larger — about 1094.8× Aterian Inc's market cap, and McCormick & Company, Incorporated pays a 3.63% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.

ATERMKC
Market Cap
$12.98M$14.21B
Sector
Consumer CyclicalConsumer Staples
52-Week High
$1.39$72.81
52-Week Low
$0.54$45.60
Enterprise Value
$13.56M$18.81B
Dividend Yield
3.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aterian Inc

Aterian (ATER) trades at $1.19, up 3.48% with a bullish technical signal despite negative profitability. Recent earnings beats and a pending asset sale that could return $0.85-$1.14 per share provide near-term catalysts. However, the company shows declining revenue from $221M in 2022 to $69M in 2025, with negative net income margins and cash flow challenges.

The outlook hinges on shareholder approval of the brand portfolio sale, offering potential shareholder returns near current price levels. Investment opportunity exists in the asset sale catalyst, but risks include ongoing operational losses, declining revenue, and negative cash flow. Analyst sentiment is evenly split between Buy and Hold recommendations.

McCormick & Company, Incorporated

McCormick (MKC) trades at $53.75, up 2.48% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 21.91% net income margin and 25.7% ROE, while valuation metrics like a P/E of 8.94 appear attractive. Recent Q2 2026 earnings beat estimates, and the company reaffirmed its 2026 outlook, supported by the transformative Unilever Foods deal announced in July 2026.

Outlook is positive with a consensus price target of $59.67 offering 11% upside, driven by margin recovery and strategic acquisitions. Risks include soft consumer volumes in the Americas and integration challenges from the Unilever deal. The stock presents a value opportunity with a 4% dividend yield, but investors should monitor volume trends and deal execution.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER

About McCormick & Company, Incorporated

In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.

Read more on MKC